New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).
Jul 5, 2023
0
82
Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments—a threat that has been met with insufficient funding ...
Oct 13, 2022
0
177
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.
May 3, 2020
0
55
Researchers say they've developed a low-cost swab test that can diagnose COVID-19 infections in about 45 minutes.
Apr 16, 2020
1
610
Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According to current estimates, only 13.8% of ...
Jan 27, 2020
0
251
Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found.
May 9, 2017
1
127
(HealthDay)—Approval by the U.S. Food and Drug Administration does not necessarily mean that a medication or medical device has received a grueling trial by fire and has been proven safe beyond all doubt, according to a ...
Jan 21, 2014
1
0
(HealthDay)—An experimental drug duo may cure some cases of the liver disease hepatitis C, without the severe side effects of standard therapy, a new clinical trial suggests.
Aug 15, 2013
0
0
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Feb 25, 2013
1
0
Washington State University researchers have developed a new drug candidate that dramatically improves the cognitive function of rats with Alzheimer's-like mental impairment.
Oct 11, 2012
7
0
